Some of you may be too young to remember, others may not have watched the show, but surely many of you will recall the Saturday Night Live sketch from the 1990s “Coffee Talk with Linda Richman,” featuring Mike Myers. For those unfamiliar, Myers played Linda Richman, a Jewish talk show host with a strong New York accent who would bring up and comment on ridiculous topics that somehow made a bit of sense (eg, the chickpea is neither a chick nor a pea). Do yourself a favor and look up an episode if you’ve never seen it.

Talking about relevant topics and new ideas, whether over coffee or not, is important to all of us in the profession of retina. Men and women have been telling stories for centuries as a means of passing on information. Despite endless inventions and innovations, none has been able to replace the role of this basic form of communication, and it’s likely that none ever will. What would life be like without storytelling, casual conversations, and deep discussions? I shudder to imagine such an existence. Fortunately, we don’t have to.

Whether they be spoken or written, our words carry weight. We rely on them to guide and to teach us and in turn to guide and to teach others. That’s the point of Retina Today—to publish timely, objective, and informative articles on subject matter that is clinically relevant to practicing retina specialists around the globe. Subject matter such as therapeutics and pharmacology, which we cover in this very issue.

If you’re not a fan of Linda Richman, no big whoop. But now it’s time to tawk amongst yourselves. I’ll give you a topic: pharmacology is neither a farm nor ecology. Discuss.

— Karen Roman, Editor-in-Chief


Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman

Janet Burk

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.